74

DAFTAR PUSTAKA

Adam, R.D. And Victor, M. 2001. Principle of Neurology, Seventh edition. Mc

Graw Hill Book Company, New York.

Adams, R., Albers, G., Alberts, M.J., et al., 2008. American Heart Association;

American Stroke Association Council on Stroke;Council on

Cardiovascular Radiology and Intervention, American Academy of

Neurology. Update to AHA/ASA Recommendation for The Prevention of

Stroke in Patients With Stroke and Transient Ischemic Attack. Stroke

39:1647-1652.

Adams, H.P., Bendixen, B.H., Kapelle, L.J., et al., 1993. Classification of subtype

of acute ischemic stroke for the TOAST Investigators. Stroke 24:35–7.

Aksoy, D., Inanir, A., Ayan, M., et al. 2013. Predictor of mortality and morbidity

in acute ischemic stroke. Archives of Neuropsychiatry.50:40-44.

Altafi, D., Khotbesara, M. H., Bagheri, A. 2013. A comparative study of NIHSS

between ischemic stroke patients with and without risk factor. Technical

journal of engineering and applied science. 3(17);1954-1957.

Anggraini, R., Was’an, M., Asmedi, A. 2008. Hiperagregasi trombosit sebagai

faktor resiko stroke iskemik. Laporan Hasil Penelitian. Bagian Ilmu

Penyakit Saraf. Fakultas Kedokteran Universitas Gadjah Mada:

Yogyakarta.

Appelros, P., Nydevik, I., Viitanen, M., 2003. Poor Outcome After First-Ever

Stroke: Predictors for Death, Dependency, and Recurent Stroke Within the

Firs Year. Stroke 34;122-126.

Asnyalan, S., Weir, C.J., Johnston, S.C., et al. 2004. Post Stroke Neurological

Improvement Wthin 7 Days Is Associated With Subsequent Deterioration

Stroke 35;2165-2170.

Bowman, T.S., Sesso, H.D., Kurth, T., et al. 2003. Cholesterol and the risk of

ischemic stroke. Stroke. 34;2930-2934.

Brainin, M., Heiss, W., 2010. Textbook of Stroke Medicine. Cambridge University

Press, Cambridge.

Castillo,J. 1999. Deteriorating Stroke: Diagnostic Criteria, Predictors, Mechanism

and Treatment. Cerebrovasc Dis 9:1-8.

Chlumsky, j., Hola, D., Kratochvilova, R., 2005. Stroke and Proinflammatory

Markers. LAB MEDICINE; 36 (4).

Connelly, P.W., Poapst, M., Davignon, J., et al. 1999. Reference Values of

Plasma Apolipoproteins A-1 and B and Association with Non lipid Risk

Factors in The Populations of Two Canadian Provinces: Quebec and

Saskatchewan. Canadian Heart Health Surveys Research Group. Can J

Cardiol. Apr; 15(4): 409-18.

Corrigan, M.L., Escuro, A.A., Kirby, D.F., 2013. Handbook of Clinical Nutrition

and Stroke. Humana Press, Springer Science & Business Media, New

York.

Dahlan, S. 2013. Besar Sampel dan Cara Pengambilan Sampel dalam Penelitian

Kedokteran dan Kesehatan. Salemba Medika : Jakarta.

75

Dananjoyo, K., Dahla, P., Setyopranoto,I. 2010. Korelasi antara kadar albumin

serum dengan skala stroke Gadjah Mada (SSGM) pada penderita stroke

iskemik akut. Laporan Hasil penelitian. Bagian Ilmu Penyakit Saraf

Universitas Gadjah Mada:Yogyakarta.

Davalos, A., Cendra, E., Teruel, J., Martinez, M., Genis, D., 1990. Deteriorating

Ischemic Stroke Risk Factor and Prognosis. NEUROLOGY 40:1865.

Davalos, A., Toni, D., Iweins, F., 1999. Neurological deterioration in Acute

Ischemic Stroke : Potential Predictors and Associated Factors in the

European Cooperative Acute Stroke Study (ECASS) I. Stroke 30; 2631-

2636.

Fletcher, R.H., Fletcher, S. W., Wagner, E. H., 1988. Clinical Epidemiology : The

Essential 2nd

ed. William&Wilkins 428, Baltimore, USA.

Elkind, M.S.V., Cheng, J., Rudek, T., et al. 2004. Leukocyte count predicts

outcome after ischemic stroke: The Northern Manhattan Stroke Study.

Journal of Stroke & Cerebrovascular Disease. 13:220-227.

Florvall, C., Basu, S., Larsson, A. 2006. Apolipoprotein is a stronger prognostic

marker than are HDL and LDL cholesterol for cardiovascular disease and

mortality in elderly men. Department of Medical Sciences, University

Hospital, S-751 85 Uppsala, Sweden.

Fisher, M.,. 2009. Handbook of Clinical Neurology : Clinical Manifestation and

pathogenesis. New York, Elsevier Inc.

Gambino, R.1997. C-Reactive Protein-Undervalued, Underutilized. Clinical

Chemistry : 43, No 11.

Giraldi, E.A., 2013. Overview of Stroke. [Cited Februari 1st, 2014] Available from

http://www.merckmanuals.com/professional/neurologic_disorders/stroke_

cva/overview_of_stroke.html.

Ghofir, A, 2011, Klasifikasi Stroke dan Jenis Patologi Stroke dalam Manajemen

Stroke Evidence Based Medicine, Pustaka Cendekia Press, Yogyakarta.

Hachinsky, V., Norris, W.J., 1985. The Acute Stroke. F.A Davis Co Philadelphia.

Han, C.I., Campbell, G.R., Campbell, J.H., 2001. Circulating bone marrow cells

can contribute to neointimal formation. J Vasc Res 38: 113–9.

Hand, P.J., Wardlaw, J.M., 2001. CT for Acute Ischemic Stroke. Practical

Neurology. 1; 82-92.

Hastuti, M., Wibowo S., Setyopranoto I. 2014. Hubungan Antara Kadar Zink (Zn)

Serum dengan Defisit Neurologis pada Pasien Stroke Iskemik akut.

Laporan Hasil Penelitian. Program Pendidikan Dokter Spesialis FK

UGM: Ygyakarta.

Hilbert, T., Lifshitz, M.S., 2007. Lipids and Dyslipoproteinemia. In Henry's

Clinical Diagnosis and Management by Laboratory. McPherson RA. New

York, Elsevier Inc. p123-341.

Hjalmasson, C., Bokemark, L., Anderson, B. 2014. The role of prestroke glycemic

control on severity and outcome of acute ischemic stroke. Stroke Research

& Treatment. In: www.researchgate.net.

76

Howard, G., Wagenknecht, L.E., Burke, G.L., Diez-Roux, A., Evans, G.W.,

McGovern, P., et al., 1998. Cigarette smoking and progression of

atherosclerosis–The atherosclerosis risk in communities (ARIC) study.

Journal of the American Medical Association 279: 119-124

Indiana Stroke Prevention Task Force. 2006. Recommendation and Guidelines for

Recognition and Intervention of Risk Factors for Stroke, Diagnosis and

Treatment of Transient Ischemic Attack, Diagnosis and Treatment of

Ischemic Stroke. New York, Elsevier Inc. P134-137.

Indiyarti, R. 2003. Dampak hiperglikemia terhadap kelangsungan hidup penderita

stroke. J Kedokter Trisakti 22(3):105-109.

Iqbal, M., Frida, M., Yaswir, R. 2014. Perbedaan rerata kadar gula darah pada

luaran stroke iskemik berdasar indeks barthel. Jurnal Kesehatan Andalas.

Fakultas Kedokteran Universitas Andalas: Padang.

Kristensen, B., Malm, J., Nilsson, T.K.,et al. 1999. Hyperhomocysteinemia and

Fibrinolysis in Young Adults With Ischemic Stroke. Stroke. 30:974-980.

Kurniasih R, Wijaya A. 2002. Peran Radikal Bebas Pada Iskemia-Reperfusi

Serebral atau Miokardium. Forum Diagnosticum, Laboratorium Klinik

Prodia.

Kurth T., Gaziano M., Berger K., et al. 2002. Body mass index and the risk of

stroke in men. Arch Int. Med. 162(22):2557-2562.

Kusbiantoro, Was’an, M., Paryono. 2011. Derajat kesadaran rendah sebagai

faktor prognostik mortalitas pada pasien stroke akut. Laporan Hasil

Penelitian. Bagian Ilmu Penyakit Saraf:Yogyakarta.

Kusuma, Y., Venketasubramanian, N., Kiemas, L.S., et al. 2009. Burden of stroke

in Indonesia. Int J Stroke 4(5):379-80.

Lapaucis, A., Wells, G., Richardson, S., et al. 1994. User’s guide to the medical

literature: How to use an article about prognosis. JAMA. 272(3);234-237.

Lawrence, W.K.S., Caplan, L.R., Jong, K.S., 2008. Stroke Mechanism. In:

Intracranial Atherosclerosis. Singapore: Blackwell Publishing Ltd, p19-

21.

Lewis, G.F., Rader, D.J., 2005. New Insights Into the Regulation of HDL

Metabolism and Reverse Cholesterol Transport. Circ Res 96:1221-32

Li Z, Xu Y, Tan S, Song B, Liu M. 2009. Study of plasma levels of ApoA-I and

ApoB for prognosis of acute ischemic stroke. Life Science Journal 6(2): 51

– 56.

Lindsay, K.W., Bone, I., Callander, R., 1997. Neurology and Neurosurgery

illustrated, 3rd

ed. Churchill Livingstone, New York.

Madjid, M., Awan, I., Willerson, J.T., et al. 2004. Leukocyte Count and Coronary

Heart Disease implications for risk assessment. J Am Coll Cardiol

44:1945-56.

Manduteanu, I., Simionescu, M., 2012. Inflammation in atherosclerosis: a cause

or a result of vascular disorders? J Cell Mol Med 16(9):1978-1990.

Marcovina, S.M, Packard, C.J., 2006. Measurement and meaning of

apolipoprotein AI and apolipoprotein B plasma levels. J Int Med 259: 437–

446.

77

Mayes, P.A., 1997. Pengangkutan dan Penyimpanan Lipid. Dalam Biokimia

Harper. Edisi 24. Penerbit EGC, Jakarta.

Misbach, J., 1999. Stroke, Aspek Diagnostik, Patofisiologi, Manajemen. Jakarta.

Balai Penerbit FKUI, p45-46.

Munir, B., Rasyid, H., Rosita, R. 2007. Hubungan antara kadar glukosa darah

acak pada saat masuk instalasi gawat darurat dengan hasil keluaran klinis

penderita stroke iskemik akut. SMF Neurologi RS Saiful Anwar: Malang.

Olofson, S., Wiklun, O., Boren, J., 2007. Apolipoproteins A-I and B: biosynthesis,

role in the development of atherosclerosis and targets for intervention

against cardiovascular disease. Vascular Health and Risk Management

3(4):491–502.

Olsson, A., Gregory, G., Szarek M. 2005. High-density lipoprotein, but not low-

density lipoprotein cholesterol levels influence short-term prognosis after

acute coronary syndrome: results from the MIRACL trial. European Heart

Journal (2005) 26, 890–896.

Paul, S.L, Thrift, A.G., Donnan, G.A., 2004. Smoking as a Crucial Independent

Determinant of Stroke. Tobacco Induced Diseases 2(2): 67-80.

Pusparini. 2002. Homosistein faktor risiko baru (non tradisional) penyakit

kardiovaskuler. J Kedokter Trisakti 21(1):31-39.

Rafi. 2002. Update in Neuroemergencies. Balai Penerbit FK UI: Jakarta.

Rifai, N., King, M.E., 1986. Immunoturbidimetric assays of apolipoproteins A,

AI, AII, and B in serum. Clin Chem Jun 32(6):957–961.

Runtuwene, L., Dahlan, P., Asmedi, A. 2008. Sindrom metabolik sebagai

prediktor outcome pasien stroke iskemik akut. Bagian Ilmu Penyakit Saraf:

Yogyakarta.

Sacco, R.L., Kasner, S.E., Broderick, J.P., et al., 2013. An Updated Definition of

Stroke for the 21st Century : A Statement for Healthcare Professionals

From the American Heart Association/American Stroke Association.

Stroke 44:2064-2089.

Samet, J.M. 2000. Concept of time in clinical research. Ann Intern. Med, 132;37-

44.

Sanossian, S., Saver, J.L., Navab, M., et al. 2007. High Density Lipoprotein

Cholesterol: An Emerging Target for Stroke Treatment. Stroke. 38;1104-

1109.

Sastroasmoro, S., 2008. Dasar-Dasar Metodologi Penelitian Klinis, Bagian Ilmu

Penyakit Anak, FK UI, Jakarta.

Sebastian, E., Kustiowati, E., Noorwijayahadi. 2013. Asosiasi genotip

Apolipoprotein E dengan keluaran pasien paska stroke iskemik. Medica

Hospitalia vol. 1(3):169-174.

Setyopranoto, I., 2012. Odem Otak pada Pasien Stroke Iskemik Akut. Penerbit

Fakultas Kedokteran Universitas Gadjah Mada, Yogyakarta

Shah, P.K., 2003. Mechanisms of plaque vulnerability and rupture. J Am Coll

Cardiol 41:S15–22.

Shan, Y.S., Da, T., Yun, Y.D., et al. 2010. Association Between Fifteen Risk

Factor and Progressing Ischemic Stroke in the Han Popuation of Northeast

China. Chin Med J. 111:1392-1396.

78

Shao-Hua, W., Zi-lin, S., Xiong-Zhong, R., et al. 2009. Dyslipidemia among

diabetic patients with ischemic stroke in a Chinese hospital. Chinese

Med J 122(21):2567-72.

Shuangxi, G., Song, T., Bo., et al., 2012. Study of the Relationship of Glycated

hemoglobin Levels and Neurological Impairment and Three Months

Prognosis in Patients with Acute Ischemic Stroke.

Simionescu, M., 2007. Implications of early structural-functional changes in the

endothelium for vascular disease. Arterioscler Thromb Vasc Biol 27: 266–

74.

Sitepu, M., Nasution, D., Arina,C. 2014. Hubungan D-dimer, gula darah dan asam

urat dengan volume stroke infark dan keluaran pada stroke iskemik.

Neurona. Departemen Neurologi FK UI/RSCM: Jakarta.

Tabas, I., Tall, A., Accili, D., 2010. The impact of macrophage insulin resistance

on advanced atherosclerotic plaque progression. Circ Res 106: 58–67.

Tan, N.C. Venketasubramanian, N., Saw, S.M., et al. 2002. Homocysteinemia and

Risk of Ischemic Stroke among Young Asian Adults. Stroke. 33:1956-

1962.

Teramoto, T, Sasaki J, Ueshima H, et al. 2007. Diagnostic Criteria for

Dyslipidemia : Executive Summary of Japan Atherosclerosis Society

(JAS) Guideline for Diagnosis and Prevention of Atherosclerotic

Cardiovascular Diseases for Japanese. J Atheroscler Thromb 14:155-158.

Thomas, 1997. Cecil essential of Medicine 4th

Edition. W.B. Saunders.

Philadelphia.184-186.

Thursina, C., 2003. Nilai Skala Stroke Gadjah Mada Saat Masuk Rumah Sakit

sebagai Prediktor Outcome Defisit Neurologis pada Penderita Stroke.

Laporan Penelitian. Bagian Ilmu Penyakit Saraf FK_UGM, Yogyakarta.

Tjandrawinata, R.R., 2013. Terapi Masa Depan Melalui Penghambatan atau

Downregulation Ekspresi Cholesteryl Ester Transfer Protein (CETP)

dalam Menurunkan Risiko Penyakit Kardiovaskular. Medicinus 26(1):5-

10.

Toni, D., Fiori, M., Bastianello, S, et al., 1997. Acute Ischemic Strokes Improving

During the First 48 hours of Onset: Predictability, Outcome, and Possible

Mechanism Stroke. 28:10-14.

Toole, J.F., 1999. Intracerebral Haemmorrhage in Cerebrovascular Disease 4th

ed. Raven Press, New York.

Urbanus, R.T., Siegerink, B., Roest, M., et al. 2009. Antiphospholipid antibodies

and risk of myocardial infarction and ischaemic stroke in young women in

the RATIO study: a case-control study. The Lancet Neurology 8(11):998 -

1005.

Wade, D.T., Wood, C.V.A., Hewer, R.L. 1985. Recovery after stroke. The first 3

months, J Neurol Neurolsurg Psychiatry; 48:7-13.

Wahjoepramono, E.J, 2005. Stroke Tata Laksana Fase Akut. Fakultas Kedokteran

Universitas Pelita Harapan, Jakarta

Walldius, G., Jungner, I., 2007. The apo B/apo A-I ratio: a strong, new risk factor

for cardiovascular disease and a target for lipid lowering therapy — a

review of the evidence. J Intern Med 259:493-519

79

Wardlaw, J.M., Marshall, I., Wild, J., et al., 1998. Studies of Acute Ischaemic

Stroke With proton Magnetic Resonance Spectroscopy Relation Between

Time from Onset, neurological deficit, Metabolite Abnormalities in the

Infarct, Blood Flow, and clinical Outcome Stroke, 29:1618-1624.

Wasan, K.M., Brocks, D.R., Lee, S.D., et al. 2008. Impact of lipoproteins on the

biological activity and disposition of hydrophobic drugs: implications for

drug discovery. Nature Reviews Drug Discovery 7:84-9

Yao, X., Geng, J., Sun, Y., et al. 2012. Age and gender specific prevalence of risk

factor in patient with first-ever ischemic stroke in China. Stroke Research

and Treatment:1-7.

Yeh, P., Yang, C., Lin, S., et al., 2013. Low Levels of High Density Lipoprotein

Cholesterol in Patient With Atherosclerotic Stroke : A Prospective Cohort

Study. Atherosclerosis 228 (2013) 472-477.

Yoo, S.H., Kim, J.S., Kwon, S.U., et al. 2008. Undernutrition as a predictor of

poor clinical outcomes in acute ischemic stroke patients. Arch

Neurol.65(1): 39-43.

Zakhari, S., 1997. Alcohol and the cardiovascular system: molecular mechanisms

for beneficial and harmful action. Alcohol Health Res World 21(1):21–9.